Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
PSB202 is comprised of an anti-CD20 monoclonal antibody and an anti-CD37 monoclonal antibody, which potentially induces B-cell killing and tumor reduction (Cancer Res 2022;82(12_Suppl):Abstract nr 2902).
|DrugClasses||CD20 Antibody 17 CD37 Antibody 8|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|